ArticleOncotarget2014

In comparative analysis of multi-kinase inhibitors for targeted medulloblastoma therapy pazopanib exhibits promising in vitro and in vivo efficacy.

Rogerio B Craveiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.